Prevention and treatment of thrombosis in cancer and oncohematological patients

Prevention and treatment of thrombosis in cancer and oncohematological patients

The purpose of the review is to highlight the current possibilities for the prevention and treatment of venous thrombotic complications in patients with cancer.The data of 52 scientific sources published in the Russian and foreign press in 1997–2020 are considered.Cancer patients are at high risk of...

Full description

Bibliographic Details
Main Authors:	O. V. Somonova, A. L. Elizarova, T. V. Davydova
Format:	Article
Language:	Russian
Published:	ABV-press 2021-11-01
Series:	Онкогематология
Subjects:	cancer patient thrombotic complication low molecular weight heparin direct oral anticoagulant
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/503

Similar Items

Treatment of cancer-related thrombosis: from recommendations to real clinical practice
by: Oksana V Somonova, et al.
Published: (2019-03-01)

The use of low molecular weight heparin Enixum® in the prevention and treatment of thrombosis in oncology
by: O V Somonova, et al.
Published: (2018-03-01)

The prospects for using bemiparin in prophylaxis and treatment of thromboses in oncology
by: O. V. Somonova, et al.
Published: (2018-07-01)

Enoxaparin sodium as a drug of choice for the treatment of thrombosis in oncology
by: О. V. Somonova, et al.
Published: (2021-06-01)

Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
by: Isabelle Mahé, et al.
Published: (2019-07-01)

THROMBOPHILIA, THROMBOSIS AND ANTITHROMBOTIC THERAPY IN CANCER PATIENTS
by: A. V. Vorobev, et al.
Published: (2016-06-01)

Updates in Anticoagulation Therapy Monitoring
by: Hannah L. McRae, et al.
Published: (2021-03-01)

Recent Advances in the Management of Cancer-Associated Thrombosis: New Hopes but New Challenges
by: Corinne Frere, et al.
Published: (2019-01-01)

Real-world Data on Treatment Patterns and Bleeding in Cancer-associated Thrombosis: Data from the TROLL Registry
by: Zygimantas Zaboras, et al.
Published: (2024-01-01)

Cancer thrombosis: Narrative review
by: Pritesh Naresh Munot, et al.
Published: (2020-01-01)

Osteoporosis and antithrombotic therapy
by: N. V. Brailova, et al.
Published: (2021-06-01)

Management of Cancer-Associated Thrombosis: An Evolving Area
by: Corinne Frere, et al.
Published: (2020-10-01)

Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism: 2022 updated systematic review and meta-analysis of randomized controlled trials
by: Corinne Frere, et al.
Published: (2022-05-01)

Current Recommendations for the Management of Cancer-Associated Venous Thromboembolism
by: Makó Katalin
Published: (2021-06-01)

Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis
by: Kaidireyahan Wumaier, et al.
Published: (2021-09-01)

Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape
by: Agnes Y.Y. Lee
Published: (2024-02-01)

Therapeutic inefficacy of protocol driven intravenous unfractionated heparin infusion in the current era
by: Kayla Torppey, et al.
Published: (2023-10-01)

Direct oral anticoagulants versus low-molecular-weight heparins for the treatment of acute venous thromboembolism in patients with gastrointestinal cancer: a systematic review and meta-analysis
by: Tarinee Rungjirajittranon, et al.
Published: (2022-07-01)

Clinical and Pathophysiological Aspects of the Effect of Anticoagulants on Bone Tissue
by: O. D. Ostroumova, et al.
Published: (2020-07-01)

Practical Considerations for the Management of Cancer-Associated Venous Thromboembolism: A Guide for the General Oncology Practitioner
by: Amye M. Harrigan, et al.
Published: (2022-09-01)

The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis
by: Hanny Al-Samkari, et al.
Published: (2018-08-01)

THE PREVENTION OF DEEP VENOUS THROMBOSIS IN NEUROSURGERY: AN UPDATE FROM OUR INSTITUTION
by: Leonello Tacconi
Published: (2018-11-01)

Cost reduction associated with heparin-induced thrombocytopenia panel ordering for enoxaparin versus heparin for prophylactic and therapeutic use: A retrospective analysis in a community hospital setting
by: Harry Menon, et al.
Published: (2018-10-01)

Ewolucja leczenia przeciwzakrzepowego – od kleszcza i pijawki do tabletki
by: Wiesława Bednarek, et al.
Published: (2010-08-01)

Cancer-Associated Thrombosis: A New Light on an Old Story
by: Sidrah Shah, et al.
Published: (2021-05-01)

Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome
by: Julie Carré, et al.
Published: (2021-12-01)

Prevention of VTE in orthopedic surgery patients
by: Federico Spandonaro, et al.
Published: (2013-10-01)

Pharmacokinetics of low molecular weight heparins in thrombosis, complicate the treatment of children with cancer
by: V. V. Dmitriev, et al.
Published: (2021-04-01)

Mitral valve nonbacterial thrombotic endocarditis: a rare multi-surgery-tolerant survivor of Trousseau’s syndrome
by: Yoshiharu Soga, et al.
Published: (2018-08-01)

Bioequivalence of a biosimilar enoxaparin (Cloti‐Xa™) and its innovator (Clexane®): A single‐dose, randomized, double‐blind, two‐period, two‐treatment, two‐sequence, crossover, balanced study in healthy human subjects
by: Sumit Saxena, et al.
Published: (2022-08-01)

Preventing Venous Thromboembolism in Ambulatory Patients with Cancer: A Narrative Review
by: Anne Rossel, et al.
Published: (2020-03-01)

THROMBOPHILIAS IN OBSTETRICIAN AND GYNECOLOGICAL PRACTICE, HEPARIN PREVENTION
by: A. P. Momot, et al.
Published: (2017-10-01)

Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after cancer surgery: a systematic review and meta-analysis
by: Hong Zhou, et al.
Published: (2024-02-01)

Primary Thromboprophylaxis in Pancreatic Cancer Patients: Why Clinical Practice Guidelines Should Be Implemented
by: Dominique Farge, et al.
Published: (2020-03-01)

Parnaparin: confronto con le altre eparine a basso peso molecolare
by: Lorenzo Pradelli
Published: (2005-09-01)

Treatment of venous thromboembolism in pregnancy: findings from the RIETE Registry
by: Paolo Prandoni, et al.
Published: (2022-05-01)

ANTITHROMBOTIC THERAPY IN CANCER PATIENTS
by: A. V. Vorobev, et al.
Published: (2016-06-01)

Anticoagulant Activity of Heparins from Different Animal Sources are Driven by a Synergistic Combination of Physical-chemical Factors
by: Stephan N.M.C.G. Oliveira, et al.
Published: (2022-10-01)

Comparative Evaluation of Efficacy, Safety and Haemostatic Parameters of Enoxaparin and Fondaparinux in Unstable Coronary Artery Disease
by: Sanjay Shah, et al.
Published: (2014-01-01)

Heparin and its derivatives in the treatment of arterial thrombosis: a review
by: M. Dvorak, et al.
Published: (2010-11-01)